Type
Closure
Country
Czechia
Region
Stredni Cechy; Stredocesky;
Location of affected unit(s)
Jevany (Bohumil)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.2 - Manufacture of pharmaceutical preparations

275 jobs
Number of planned job losses
Job loss
Announcement Date
28 January 2014
Employment effect (start)
Foreseen end date
28 February 2014

Description

Pharmaceuticals producer Baxter BioScience is to close down its manufacturing plant in Bohumil-Jevany near Prague, resulting in 275 job losses by the end of February 2014.

This is due to the termination of the company’s vaccine production at the plant. The company announced that it will focus on its core activities, particularly on blood plasma products.

The firm intends to offer some workers an internal relocation. Furthermore, it will offer job search services for external jobs. In addition to a statutory compensation, the redundant workers will be given a voluntary severance pay on the basis of seniority.

Baxter BioScience is a subsidiary of the multinational pharmaceutical company Baxter International which employs 51,000 people worldwide.


Sources

  • 28 January 2014: Deník

Citation

Eurofound (2014), Baxter BioScience, Closure in Czechia, factsheet number 76521, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/76521.